BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 30235289)

  • 1. How do organisational configuration and context influence the quantity and quality of NHS services provided by English community pharmacies? A qualitative investigation.
    Jacobs S; Fegan T; Bradley F; Halsall D; Hann M; Schafheutle EI
    PLoS One; 2018; 13(9):e0204304. PubMed ID: 30235289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organisational and extraorganisational determinants of volume of service delivery by English community pharmacies: a cross-sectional survey and secondary data analysis.
    Hann M; Schafheutle EI; Bradley F; Elvey R; Wagner A; Halsall D; Hassell K; Jacobs S
    BMJ Open; 2017 Oct; 7(10):e017843. PubMed ID: 29018074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumers' expectations and experiences with chain community pharmacies in Lahore, Pakistan: a qualitative exploratory study.
    Asif U; Saleem A; Masood I; Nawaz M
    Int J Clin Pharm; 2019 Jun; 41(3):813-819. PubMed ID: 31028597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
    Hindi AMK; Schafheutle EI; Jacobs S
    BMC Fam Pract; 2019 Feb; 20(1):26. PubMed ID: 30736732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Professional stakeholders' expectations for the future of community pharmacy practice in England: a qualitative study.
    Paloumpi E; Ozieranski P; Watson MC; Jones MD
    BMJ Open; 2023 Oct; 13(10):e075069. PubMed ID: 37844992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "What counts can't always be measured": a qualitative exploration of general practitioners' conceptualisation of quality for community pharmacy services.
    Watson M; Silver K; Watkins R
    BMC Fam Pract; 2020 Nov; 21(1):244. PubMed ID: 33248452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research.
    Frisk P; Holtendal C; Bastholm-Rahmner P; Sporrong SK
    Int J Pharm Pract; 2019 Aug; 27(4):346-354. PubMed ID: 30707481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers' and commissioners' perceptions of the Healthy Living Pharmacy framework.
    Firth H; Todd A; Bambra C
    Perspect Public Health; 2015 Sep; 135(5):251-6. PubMed ID: 25868465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitness for purpose of pharmacy technician education and training: The case of Great Britain.
    Schafheutle EI; Jee SD; Willis SC
    Res Social Adm Pharm; 2017; 13(1):88-97. PubMed ID: 26827123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.